drugset
drugset / Trial / NCT01982916

Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean

NCT01982916 ↗

Phase 3 Completed 324 enrolled Ahn-Gook Pharmaceuticals Co.,Ltd Inha University Hospital · collabKonkuk University Medical Center · collabKyunghee University Medical Center · collabSMG-SNU Boramae Medical Center · collabSamsung Medical Center · collabSeoul National University Bundang Hospital · collabSeoul National University Hospital · collabSeoul St. Mary's Hospital · collabSeverance Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate treatment of perennial allergic rhinitis in Korean patients with AGR tablet.

Timeline

Start
2013-12
Primary completion
2015-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject AGR Unknown — —

Indications

perennial allergic rhinitis